Health and Medicine

October 31, 2013

Knowing who their physician is boosts patient satisfaction

Knowing who your doctor is — and a couple of facts about that person — may go a long way toward improving patient satisfaction, according to a Vanderbilt study in the Journal of Orthopaedic Trauma.

By Craig Boerner
October 31, 2013

Pioneers of Discovery: Investigator driven to divine cellular ecosystem’s rulebook

Ken Lau, Ph.D., a new assistant professor in Cell and Developmental Biology, is out to determine the rules that lead to cells converting from one type to another, for example, when a healthy cell becomes a cancer cell.

By Bill Snyder
DNA sequence
October 31, 2013

VU ‘crosslinks’ study sheds light on chemical toxicity

Vanderbilt researchers have characterized the chemical structures of a series of DNA-protein “crosslinks” that may lead to better ways to avoid the cancer-causing potential of environmental chemicals and prevent some drug toxicities.

By Bill Snyder
October 30, 2013

Preserving antibiotic arsenal for TB

Clinicians should be cautious about prescribing newer fluoroquinolone antibiotics to patients with TB risk factors; doing so may jeopardize the use of these agents against TB.

By Leigh MacMillan
October 29, 2013

Vanderbilt to study use of plasma on LifeFlight

Vanderbilt University Medical Center will participate in a national trial to see if outcomes for critically injured patients with uncontrolled bleeding can be improved by administering plasma to these patients while in flight to the hospital.

By VUMC News and Communications
October 28, 2013

Tool predicts risk for developmental delays in early childhood

A non-invasive measure of electrical brain activity in preterm infants predicts cognitive and communication functioning during early childhood, according to a new Vanderbilt University study.

By Leigh MacMillan
October 25, 2013

Targets of SIN drive cell division

Vanderbilt researchers have identified a key regulator of cell division.
By Leigh MacMillan
October 24, 2013

Grad students help achieve key discovery

A multidisciplinary study conducted by the combined efforts of Vanderbilt University graduate students has led to the first evidence that abnormal messenger RNA export from the nucleus to the cytoplasm can cause human disease.
By Bill Snyder
October 24, 2013

Glucose control study gives patients new path to health

The IDIOM study is designed to compare how a diet with moderate caloric restriction, alone or with long-acting insulin, affects areas of the brain’s dopamine system that are involved in food intake, reward and the sense of pleasure people get from eating.
By Jessica Pasley
October 24, 2013

Study sheds new light on type 2 diabetes development

Inactivation by oxidative stress of specific transcription factors essential for pancreatic islet beta cell function is a key event in the development of type 2 diabetes, Vanderbilt University researchers and their colleagues have found.
By Bill Snyder
October 24, 2013

Shining a light on night blindness

Vanderbilt researchers are studying how mutations in the receptor for light, rhodopsin, cause light blindness.
By VUMC News and Communications
October 21, 2013

Frisse, Weiner elected to Institute of Medicine

Vanderbilt University’s Betsy Weiner, Ph.D., R.N., senior associate dean for Informatics in the School of Nursing, and Mark Frisse, M.D., MS, MBA, Accenture Professor and director of Regional Informatics, have been elected to the Institute of Medicine (IOM), the organization announced this week.
By Bill Snyder
October 17, 2013

Frog-killing fungus paralyzes amphibian immune response

A fungus that is killing frogs and other amphibians around the world releases a toxic factor that disables the amphibian immune response, Vanderbilt University investigators report Oct. 18 in the journal Science.
By Leigh MacMillan
1 … 145 146 147 148 149 … 192